Chen 2016: Cancer statistics in China, 2015
The first national cancer estimate for China built from population registries, projecting about 4.3 million new cancer cases in 2015, with lung cancer the most common cancer and leading cause of cancer death, and stomach, oesophageal and liver cancers far more prominent than in Western countries.
Overview
Chen and colleagues at China's National Cancer Center used data from 72 local population-based cancer registries covering 2009 to 2011, about 6.5% of the population, to project cancer incidence and mortality in China for 2015. They estimated about 4.3 million new cases and 2.8 million deaths. Lung cancer was the most common cancer and the leading cause of death, followed by stomach, oesophageal, liver and colorectal cancers, and the report documented rising incidence in cities alongside higher mortality in rural areas, as well as a large burden of infection-related cancers.
- About 4,292,000 new cancer cases and 2,814,000 cancer deaths projected for China in 2015.
- Lung cancer the most common cancer and leading cause of cancer death; stomach, oesophageal, liver and colorectal cancers next.
- Based on 72 population-based registries covering about 6.5% of the population; rural areas had higher mortality than cities.
China accounts for roughly a quarter of the world's cancer cases, and this paper is the reference that made its burden legible internationally. It explains why Chinese trial programmes and drug pipelines concentrate on lung, stomach, oesophageal and liver cancers.
- Registries covered a small, mainly urban share of the population, so estimates involve substantial extrapolation.
- Later National Cancer Center reports have updated the figures.
Similar pages
not linked directly; found by shared links- Key paperFitzmaurice 2017: the Global Burden of Disease estimate of cancer in 2015
Shares Incidence versus prevalence, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, Non-small-cell lung cancer.
- Key paperAllemani 2018: CONCORD-3, global surveillance of cancer survival 2000 to 2014
Shares Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, Hepatocellular carcinoma, Colorectal cancer.
- Key paperTorre 2015: Global cancer statistics, 2012
Shares Incidence versus prevalence, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, Non-small-cell lung cancer.
- Key paperSung 2021: GLOBOCAN 2020, the year breast cancer overtook lung cancer as the most diagnosed cancer
Shares Incidence versus prevalence, Bray 2018: GLOBOCAN 2018, worldwide incidence and mortality for 36 cancers, Mortality, Colorectal cancer.
- Key paperSiegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report
Shares Incidence versus prevalence, Mortality, Colorectal cancer.
- Key paperCalle 2003: overweight, obesity and death from cancer in 900,000 US adults
Shares Mortality, Hepatocellular carcinoma, Colorectal cancer.
- PersonJie He
Shares National Cancer Center of China, Non-small-cell lung cancer.
- InstitutionTaipei Veterans General Hospital
Shares Hepatocellular carcinoma, Gastric & gastro-oesophageal junction cancer, Colorectal cancer, Non-small-cell lung cancer.